XML 76 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS (USD $)
In Thousands, unless otherwise specified
9 Months Ended
Jun. 30, 2013
Jun. 30, 2012
OPERATING ACTIVITIES:    
Net income $ 576,842 $ 423,930
Adjustment for (income) loss from discontinued operations (15,186) 73
Income from continuing operations 561,656 424,003
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation 336,822 272,404
Provision for bad debt 3,781 2
Stock-based compensation 17,471 13,300
Other 1,156 134
Gain on sale of investment securities (162,121)  
Income from asset sales (14,538) (14,365)
Deferred income tax expense 15,822 144,729
Change in assets and liabilities:    
Accounts receivable (5,697) (143,809)
Inventories (10,009) (16,012)
Prepaid expenses and other 15,564 (41,287)
Accounts payable (62,830) (13,899)
Accrued liabilities 83,290 (7,768)
Deferred income taxes (1,291) (326)
Other noncurrent liabilities (17,619) (4,055)
Net cash provided by operating activities from continuing operations 761,457 613,051
Net cash provided by (used in) operating activities from discontinued operations 186 (73)
Net cash provided by operating activities 761,643 612,978
INVESTING ACTIVITIES:    
Capital expenditures (618,550) (774,243)
Proceeds from sale of investment securities 232,221  
Proceeds from asset sales 21,729 31,838
Net cash used in investing activities from continuing operations (364,600) (742,405)
Net cash provided by investing activities from discontinued operations 15,000  
Net cash used in investing activities (349,600) (742,405)
FINANCING ACTIVITIES:    
Repurchase of common stock   (71,404)
Increase in bank overdraft   3,955
Dividends paid (39,519) (22,620)
Exercise of stock options 6,118 2,374
Tax withholdings related to net share settlements of restricted stock (1,677) (1,514)
Excess tax benefit from stock-based compensation 7,420 3,256
Net cash used in financing activities (27,658) (85,953)
Net increase (decrease) in cash and cash equivalents 384,385 (215,380)
Cash and cash equivalents, beginning of period 96,095 364,246
Cash and cash equivalents, end of period $ 480,480 $ 148,866